Kuwait’s Ministry of Health has issued a major new decision. This decision comprehensively regulates private pharmacy licenses. Minister of Health Dr. Ahmad Al-Awadhi officially announced the rules on Sunday. The move aims to significantly strengthen pharmaceutical sector governance.
The new ministerial decision introduces strict controls. These controls govern the circulation of medicines nationwide. Furthermore, they also apply to all medical products. A ministry statement explained the decision’s primary goals.
The rules aim to strengthen the drug control system. They also consolidate governance principles in the pharmaceutical sector. Consequently, this ensures greater drug safety for the community. The decision also promotes efficient and professional practice.
This initiative is part of broader modernization efforts. It updates the regulatory framework for private pharmacies. Additionally, it keeps pace with rapid developments in pharmaceutical services. The decision directly supports the goals of Kuwait Vision 2035.
The ministry describes this as a qualitative shift. It fundamentally regulates the relationship between pharmacists and the community. The decision establishes clear guidelines for licensing. It also sets rules for pharmacy management and daily operations.
The regulations tighten controls in several key areas. These areas include drug storage and proper dispensing. The rules also cover pricing and advertising of medicines. Finally, they set standards for delivery services.
The comprehensive decision contains thirteen detailed articles. It covers all aspects of private pharmacy operations. This includes everything from initial establishment to final closure. The ultimate goal is promoting disciplined professional conduct.
Moreover, these measures actively protect consumer health. The ministry reiterated its overarching vision. It seeks to build an organized and safe pharmaceutical sector. This focus on robust pharmaceutical sector governance will foster innovation.
The new framework also encourages greater professionalism. It safeguards patients and society within an integrated health system. This system is founded on justice and transparency. The decision marks a key step in advancing pharmaceutical sector governance for Kuwait.
